<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03491475</url>
  </required_header>
  <id_info>
    <org_study_id>UniverstairZB</org_study_id>
    <nct_id>NCT03491475</nct_id>
  </id_info>
  <brief_title>Echocardiography During Ajmaline Test</brief_title>
  <official_title>Dynamicity of Echocardiography During Ajmaline Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitair Ziekenhuis Brussel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitair Ziekenhuis Brussel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators analyse echocardiographic images before and during Ajmaline
      test. The purpose is to know if any echocardiographic modifications are present during either
      negative or positive Ajmaline testing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The diagnosis of Brugada Syndrome is made when a type 1 pattern is present on the
      electrocardiogram (ECG), either spontaneously or after administration of a sodium channel
      blocker. For pathofysiological understanding, the investigators will analyse echocardiography
      images before and during the administration of Ajmaline. Comparing echocardiographies before
      and during negative Ajmaline test, will allow the investigators to indentify the effect of
      Ajmaline administration on cardiac function. The comparison between images of negative and
      positive Ajmaline tests will expose differences related to the occurence of a type 1 ECG.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 26, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Speckle tracking strain measurement</measure>
    <time_frame>1 day at the time of enrollment</time_frame>
    <description>Cardiac function assessed by speckle tracking peak strain and peak strain dispersion</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Brugada Syndrome</condition>
  <arm_group>
    <arm_group_label>Negative Ajmaline test</arm_group_label>
    <description>No appearance of a type 1 ECG during Ajmaline test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Positive Ajmaline test</arm_group_label>
    <description>Appearance of a type 1 ECG during Ajmaline test</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ajmaline test</intervention_name>
    <description>Administration of Ajmaline</description>
    <arm_group_label>Negative Ajmaline test</arm_group_label>
    <arm_group_label>Positive Ajmaline test</arm_group_label>
    <other_name>Echocardiography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients referred for Ajmaline test, either because of symptoms or in the context of
        familial screening.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;17 years old

          -  clinical indication for Ajmaline test

        Exclusion Criteria:

          -  History of right ventricular outflow tract ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esther Scheirlynck, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitair Ziekenhuis Brussel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Esther Scheirlynck, MD</last_name>
    <phone>+3228012461</phone>
    <email>esther.scheirlynck@uzbrussel.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ingrid Lemoine</last_name>
    <email>ingrid.lemoine@uzbrussel.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UZ Brussel</name>
      <address>
        <city>Jette</city>
        <state>Brussels</state>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine De Greef</last_name>
      <email>catherine.degreef@uzbrussel.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>April 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2018</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitair Ziekenhuis Brussel</investigator_affiliation>
    <investigator_full_name>Esther Scheirlynck</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ajmaline test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brugada Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ajmaline</mesh_term>
    <mesh_term>Lorajmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

